HGF and pulmonary fibrosis: In murine models, overexpression of hepatocyte growth factor (HGF) and inhibition of profibrotic NADPH oxidase 4 (NOX4) in VECs creates a modified vascular microenvironment in the liver and lung tissue that promotes liver and lung fibrosis.